Magnetic resonance imaging during intracavitary gynecologic brachytherapy.

The cases of three patients, two with Stage III-B and one with Stage II-B carcinoma of the cervix, are cited to illustrate specific advantages of magnetic resonance (MR) imaging over computed tomography (CT) during intracavitary gynecologic brachytherapy. CT and MR were performed during the first of two intracavitary implants. To obtain artifact-free images with the intracavitary implant in place, a CT- and MR-compatible Fletcher system applicator was used. Although CT failed to differentiate the cervical tumor clearly from surrounding tissues, the area of pathology could be identified on MR by comparing the T1-weighted (T1W) and T2-weighted (T2W) images. Cervical tumors typically exhibit low-signal intensity on T1W and high-signal intensity on T2W scans, whereas paracervical soft tissues demonstrate high intensity on both T1W and T2W images. This contrast permits the size, location, and paracervical involvement of the tumor to be defined by MR. Multiplanar MR images obtained during the patients' intracavitary brachytherapy help demonstrate the actual anatomic relationship between the tumor and the applicator. Isodose distributions displayed on these images show that, in two cases, the tumor margin extended beyond the prescribed isodose line. Thus, MR may prove to be a clinically useful reference during intracavitary brachytherapy for ascertaining radiation dose to actual tumor volume.